Public Calendar: January 22-28, 2023
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs
No Significant Event
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
No Significant Event
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 01/24/2023
Location: Virtual
Subject: Food Integrity U.S. 2023 Online Summit; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and other stakeholders
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
Event Date: 01/25/2023
Location: Virtual
Subject: Office of Global Policy and Strategy Newsletter Interview
FDA Participant/Group: KAREN RILEY;
Non FDA Participant/Group: Paul Huleatt (World Health Organization Member State Mechanism on Substandard and Falsified Medical Products);
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 01/24/2023
Location: Virtual
Subject: Duke Clinical Research Institute Research Forum: Unlocking the Promise of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare and academia stakeholders
Event Date: 01/25/2023
Location: Virtual
Subject: Precision Medicine World Conference 2023 - Gene and Cell Therapies Track; Panel Chair: From Bench to Bedside - Biomarkers, Natural History Studies, Animal Models
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare, academia, and research stakeholders
Event Date: 01/26/2023
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee; Welcome Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and public stakeholders
Event Date: 01/27/2023
Location: Washington, DC
Subject: Alliance for Aging Research and American Society of Consultant Pharmacists; Panelist: Our Best Shot: A Roundtable on Expanding Vaccine Access for Long-Term Care Residents
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare and public stakeholders
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 01/24/2023
Location: Virtual
Subject: Listening Session: Presentation on the Evaluation of Action on Smoking and Health (ASH) Canada’s Tobacco Retailer Advanced Compliance (TRAC) Online Training Program
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Action on Smoking and Health (ASH) Canada
Official Name: Tracey H. Forfa, J.D., Acting Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event